Literature DB >> 17037983

Regulation of the human mucin MUC4 by taurodeoxycholic and taurochenodeoxycholic bile acids in oesophageal cancer cells is mediated by hepatocyte nuclear factor 1alpha.

Guillaume Piessen1, Nicolas Jonckheere, Audrey Vincent, Brigitte Hémon, Marie-Paule Ducourouble, Marie-Christine Copin, Christophe Mariette, Isabelle Van Seuningen.   

Abstract

MUC4 (mucin 4) is a membrane-bound mucin overexpressed in the early steps of oesophageal carcinogenesis and implicated in tumour progression. We previously showed that bile acids, main components of gastro-oesophageal reflux and tumour promoters, up-regulate MUC4 expression [Mariette, Perrais, Leteurtre, Jonckheere, Hemon, Pigny, Batra, Aubert, Triboulet and Van Seuningen (2004) Biochem. J. 377, 701-708]. HNF (hepatocyte nuclear factor) 1alpha and HNF4alpha transcription factors are known to mediate bile acid effects, and we previously identified cis-elements for these factors in MUC4 distal promoter. Our aim was to demonstrate that these two transcription factors were directly involved in MUC4 activation by bile acids. MUC4, HNF1alpha and HNF4alpha expressions were evaluated by immunohistochemistry in human oesophageal tissues. Our results indicate that MUC4, HNF1alpha and HNF4alpha were co-expressed in oesophageal metaplastic and adenocarcinomatous tissues. Studies at the mRNA, promoter and protein levels indicated that HNF1alpha regulates endogenous MUC4 expression by binding to two cognate cis-elements respectively located at -3332/-3327 and -3040/-3028 in the distal promoter. We also showed by siRNA (small interfering RNA) approach, co-transfection and site-directed mutagenesis that HNF1alpha mediates taurodeoxycholic and taurochenodeoxycholic bile acid activation of endogenous MUC4 expression and transcription in a dose-dependent manner. In conclusion, these results describe a new mechanism of regulation of MUC4 expression by bile acids, in which HNF1alpha is a key mediator. These results bring new insights into MUC4 up-regulation in oesophageal carcinoma associated with bile reflux.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17037983      PMCID: PMC1783985          DOI: 10.1042/BJ20061461

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  46 in total

Review 1.  Molecular biology of Barrett's adenocarcinoma.

Authors:  B P Wijnhoven; H W Tilanus; W N Dinjens
Journal:  Ann Surg       Date:  2001-03       Impact factor: 12.969

2.  Aberrant expression of human mucin gene MUC5B in gastric carcinoma and cancer cells. Identification and regulation of a distal promoter.

Authors:  M Perrais; P Pigny; M P Buisine; N Porchet; J P Aubert; I Van Seuningen-Lempire
Journal:  J Biol Chem       Date:  2001-01-30       Impact factor: 5.157

3.  Mucin gene expression and cell differentiation in human normal, premalignant and malignant esophagus.

Authors:  P Guillem; V Billeret; M P Buisine; J F Flejou; M Lecomte-Houcke; P Degand; J P Aubert; J P Triboulet; N Porchet
Journal:  Int J Cancer       Date:  2000-12-15       Impact factor: 7.396

4.  MUC4 is a novel prognostic factor of extrahepatic bile duct carcinoma.

Authors:  Shugo Tamada; Hiroaki Shibahara; Michiyo Higashi; Masamichi Goto; Surinder K Batra; Kohzoh Imai; Suguru Yonezawa
Journal:  Clin Cancer Res       Date:  2006-07-15       Impact factor: 12.531

5.  Her-2/neu gene amplification, elevated mRNA expression, and protein overexpression in the metaplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus.

Authors:  A Walch; K Specht; K Bink; H Zitzelsberger; H Braselmann; M Bauer; M Aubele; H Stein; J R Siewert; H Höfler; M Werner
Journal:  Lab Invest       Date:  2001-06       Impact factor: 5.662

Review 6.  Mutations in the human genes encoding the transcription factors of the hepatocyte nuclear factor (HNF)1 and HNF4 families: functional and pathological consequences.

Authors:  G U Ryffel
Journal:  J Mol Endocrinol       Date:  2001-08       Impact factor: 5.098

7.  Barrett's metaplasia.

Authors:  J A Jankowski; R F Harrison; I Perry; F Balkwill; C Tselepis
Journal:  Lancet       Date:  2000-12-16       Impact factor: 79.321

8.  Sequence of the 5'-flanking region and promoter activity of the human mucin gene MUC5B in different phenotypes of colon cancer cells.

Authors:  I Van Seuningen; M Perrais; P Pigny; N Porchet; J P Aubert
Journal:  Biochem J       Date:  2000-06-15       Impact factor: 3.857

Review 9.  Hepatocyte nuclear factor 1, a transcription factor at the crossroads of glucose homeostasis.

Authors:  M Pontoglio
Journal:  J Am Soc Nephrol       Date:  2000-11       Impact factor: 10.121

10.  Mucin gene expression in Barrett's oesophagus: an in situ hybridisation and immunohistochemical study.

Authors:  G S Arul; M Moorghen; N Myerscough; D A Alderson; R D Spicer; A P Corfield
Journal:  Gut       Date:  2000-12       Impact factor: 23.059

View more
  21 in total

Review 1.  Structure, evolution, and biology of the MUC4 mucin.

Authors:  Pallavi Chaturvedi; Ajay P Singh; Surinder K Batra
Journal:  FASEB J       Date:  2007-11-16       Impact factor: 5.191

2.  Transcriptional regulation of human mucin gene MUC4 in pancreatic cancer cells.

Authors:  Jingjing Zhang; Xiongfei Zhang; Yi Zhu; Zheng Chen; Zekuan Xu; Yi Miao
Journal:  Mol Biol Rep       Date:  2009-09-16       Impact factor: 2.316

Review 3.  Molecular mechanisms of Barrett's esophagus.

Authors:  Hao Chen; Yu Fang; Whitney Tevebaugh; Roy C Orlando; Nicholas J Shaheen; Xiaoxin Chen
Journal:  Dig Dis Sci       Date:  2011-10-08       Impact factor: 3.199

4.  miR-219-1-3p is a negative regulator of the mucin MUC4 expression and is a tumor suppressor in pancreatic cancer.

Authors:  F Lahdaoui; Y Delpu; A Vincent; F Renaud; M Messager; B Duchêne; E Leteurtre; C Mariette; J Torrisani; N Jonckheere; I Van Seuningen
Journal:  Oncogene       Date:  2014-03-10       Impact factor: 9.867

5.  Transmembrane mucins as novel therapeutic targets.

Authors:  Pamela E Constantinou; Brian P Danysh; Neeraja Dharmaraj; Daniel D Carson
Journal:  Expert Rev Endocrinol Metab       Date:  2011-11

Review 6.  Muc4/MUC4 functions and regulation in cancer.

Authors:  Kermit L Carraway; George Theodoropoulos; Goldi A Kozloski; Coralie A Carothers Carraway
Journal:  Future Oncol       Date:  2009-12       Impact factor: 3.404

Review 7.  Role of ErbB family receptor tyrosine kinases in intrahepatic cholangiocarcinoma.

Authors:  Alphonse-E Sirica
Journal:  World J Gastroenterol       Date:  2008-12-14       Impact factor: 5.742

8.  Bile acids-mediated overexpression of MUC4 via FAK-dependent c-Jun activation in pancreatic cancer.

Authors:  Suhasini Joshi; Eric Cruz; Satyanarayana Rachagani; Sushovan Guha; Randall E Brand; Moorthy P Ponnusamy; Sushil Kumar; Surinder K Batra
Journal:  Mol Oncol       Date:  2016-04-29       Impact factor: 6.603

9.  Transcriptional regulation of human MUC4 gene: identification of a novel inhibitory element and its nuclear binding protein.

Authors:  Jing-Jing Zhang; Yi Zhu; Xiong-Fei Zhang; Wen-Biao Liang; Kun-Ling Xie; Jin-Qiu Tao; Yun-Peng Peng; Ze-Kuan Xu; Yi Miao
Journal:  Mol Biol Rep       Date:  2013-06-30       Impact factor: 2.316

10.  The MUC4 mucin mediates gemcitabine resistance of human pancreatic cancer cells via the Concentrative Nucleoside Transporter family.

Authors:  N Skrypek; B Duchêne; M Hebbar; E Leteurtre; I van Seuningen; N Jonckheere
Journal:  Oncogene       Date:  2012-05-14       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.